Drug Design, Development and Therapy (Oct 2019)

Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice

  • Zhu Y,
  • Li ZL,
  • Ding A,
  • Yang H,
  • Zhu WP,
  • Cui TX,
  • Zhang HT,
  • Zhang H

Journal volume & issue
Vol. Volume 13
pp. 3657 – 3667

Abstract

Read online

Ye Zhu,1,* Ze-Liang Li,2,* Ao Ding,1,* Hui Yang,3,* Wei-Ping Zhu,1 Tong-Xia Cui,1 Hui-Tao Zhang,4 Hua Zhang1 1Department of Nephrology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai 519000, People’s Republic of China; 2Department of Medical Imaging, Cangzhou Hospital of Integrated Traditional Chinese Medicine-Western Medicine, Cangzhou 061001, People’s Republic of China; 3Department of Rheumatology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai 519000, People’s Republic of China; 4Center for Interventional Medicine, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai 519000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Ye ZhuDepartment of Nephrology, The Fifth Affiliated Hospital of Sun Yat-sen University, Mei Hua Dong Road, No. 52, Zhuhai 519000, People’s Republic of ChinaTel +86-756-2528701Email [email protected]: Diabetic nephropathy (DN) is a common complication of diabetes mellitus (DM) and also a major cause of end-stage renal disease (ESRD). Olmesartan medoxomil (OM) is an angiotensin II receptor blocker (ARB) and has been shown to exhibit renoprotective effects on a streptozotocin (STZ)-induced diabetic rat model. Yet, whether OM affects DN progression and renal injury in db/db mice, a type 2 diabetic murine model, has not been established.Methods: Wild-type (n = 15) and db/db mice (n = 15) were treated with control saline or OM via oral gavage. The physiological and biochemical parameters were evaluated and histological examinations of kidney specimens were performed.Results: Compared with saline-treated db/db mice, db/db mice administered with OM showed ameliorated diabetic physiological and biochemical parameters. In addition, OM decreased urinary albumin excretion and plasma creatinine level in db/db mice. Moreover, histologically, OM reduced glomerular hypertrophy and injury, and also ameliorated tubular injury, thus suggesting that OM improves renal function and minimizes renal pathological deterioration in db/db mice.Conclusion: Our study reveals a beneficial role of OM in ameliorating DN in db/db mice, which is associated with its renoprotective function.Keywords: olmesartan medoxomil, angiotensin II, renal injury, diabetic nephropathy, db/db mice

Keywords